Community-acquired left-sided Pseudomonas aeruginosa endocarditis in a patient without intravenous drug use

Infection

Volumn 41, Issue 1, 2013, Pages 243-245

  Yilmaz, M ^a   Sunar, H ^b   Mert, A ^a  

^a ISTANBUL MEDIPOL UNIVERSITY   (Turkey)

^b Kosuyolu Kartal Heart Training and Research Hospital   (Turkey)

Author keywords

Community acquired infection; Left sided endocarditis; Pseudomonas aeruginosa

Indexed keywords

ALBUMIN; AMIKACIN; ANTIPYRETIC AGENT; C REACTIVE PROTEIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; GLOBULIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ALBUMIN BLOOD LEVEL; ANOREXIA; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CASE REPORT; COMMUNICABLE DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FACIAL NERVE PARALYSIS; FEVER; HUMAN; INTRAVENOUS DRUG ABUSE; LABORATORY TEST; MALAISE; MALE; MEAN CORPUSCULAR VOLUME; MINIMUM INHIBITORY CONCENTRATION; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; PSEUDOMONAS INFECTION; SYSTOLIC HEART MURMUR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; WEIGHT REDUCTION;

ADULT; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS, BACTERIAL; HEART VALVE PROSTHESIS; HUMANS; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84873724693     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0306-x     Document Type: Article

References (13)

1. Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection. 2012;. doi: 10.1007/s15010-012-0285-y.
2. Sandre RM, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis. 1996;22:276-86.
3. Komshian SV, Tablan OC, Palutke W, Reyes MP. Characteristics of left-sided endocarditis due to Pseudomonas aeruginosa in the Detroit Medical Center. Rev Infect Dis. 1990;12:693-702.
4. Reyes MP, Lerner AM. Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa. Rev Infect Dis. 1983;5:314-21.
5. Gavin PJ, Suseno MT, Cook FV, Peterson LR, Thomson RB Jr. Left-sided endocarditis caused by Pseudomonas aeruginosa: successful treatment with meropenem and tobramycin. Diagn Microbiol Infect Dis. 2003;47:427-430. doi: S0732889303001354.
6. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-8. doi: 10.1086/313753.
7. Dawson NL, Brumble LM, Pritt BS, Yao JD, Echols JD, Alvarez S. Left-sided Pseudomonas aeruginosa endocarditis in patients without injection drug use. Medicine (Baltimore). 2011;90:250-5. doi: 10.1097/MD.0b013e3182252133.
8. Reyes MP, Palutke WA, Wylin RF. Pseudomonas endocarditis in the Detroit Medical Center. 1969-1972. Medicine (Baltimore). 1973;52:173-194. doi: 00005792-197305000-00001.
9. Marcus N, Ashkenazi S, Samra Z, Cohen A, Livni G. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment. Infection. 2008;36:421-6. doi: 10.1007/s15010-008-7328-4.
10. Weissler A, Perl L, Neuman Y, Mekori YA, Mor A. Neurologic manifestations as presenting symptoms of endocarditis. Isr Med Assoc J. 2010;12:472-6.
11. Snygg-Martin U, Gustafsson L, Rosengren L, Alsiö A, Ackerholm P, Andersson R, et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis. 2008;47:23-30. doi: 10.1086/588663.
12. Martindale JL, Hayden EM. Neurologic complaints in a patient with infective endocarditis. J Emerg Med. 2011;. doi: 10.1016/j.jemermed.2011.05.026.
13. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother. 1999;43:1379-82.